Last 58.05 INR
Change Today -0.90 / -1.53%
Volume 37.4K
As of 7:05 AM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

bal pharma ltd (BLP) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/6/14 - 77.75
52 Week Low
09/4/13 - 14.20
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BAL PHARMA LTD (BLP)

Related News

No related news articles were found.

bal pharma ltd (BLP) Related Businessweek News

No Related Businessweek News Found

bal pharma ltd (BLP) Details

Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (API) in India. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It also provides a range of APIs for various therapeutic areas, including acne treatment, diuretic, anti-histamine, anti-inflammatory, anti-diabetic, sedative/hypnotic, anti-allergy, neuropathic pain, urinary incontinence, anti-convulsant, and insomnia. The company also provides ayurvedic products comprising ANARSHA for regularize bowl movement; Ashwamed for sexual and general debility; AYURFINE and AYURFINE forte anti arthritics for osteoarthritis, rheumatoid arthritis, and spondylitis; Ayursulin for managing diabetes; IMMUWIN, an immune building supplement; and Lipived for reducing cholesterol. Its ayurvedic products also consists of MENOLEAP capsules and syrup for menstrual disorders; PROLIFE, which provides life to ailing liver; BALPRO SYRUP for stable and synchronized liver functions; PROSTOWIN for benign prostatic hyperplasia; STONEX for expulsion of kidney stones; Sujirna for digestion; Suswas, an antallergic/antiasthamatic product; and Balvac, a mild laxative. The company also exports its products to Europe, Latin America, Africa, the Middle East, and Asian markets. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.

Founded in 1987

bal pharma ltd (BLP) Top Compensated Officers

Managing Director, Executive Director, Member...
Total Annual Compensation: 6.0M
Whole-Time Director and Chairman of Banking T...
Total Annual Compensation: 2.7M
Compensation as of Fiscal Year 2014.

bal pharma ltd (BLP) Key Developments

Bal Pharma Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2014

Bal Pharma Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported net sales of INR 423.403 million compared to INR 377.021 million reported in the same period last year. Profit from operations before other income, interest and exceptional items was INR 28.831 million against INR 29.032 million reported last year. Profit from ordinary activities before tax was INR 13.161 million against INR 11.623 million reported last year. Net profit was INR 9.841 million or INR 0.78 per diluted share against INR 9.145 million or INR 0.86 per diluted share reported last year.

Bal Pharma Limited, Board Meeting, Aug 11, 2014

Bal Pharma Limited, Board Meeting, Aug 11, 2014. Agenda: To consider quarterly results.

B.N.Pranesh Ceases to Be the Nominee Director of EXIM Bank on the Board of Bal Pharma Limited

Bal Pharma Limited has announced that as per the communication received from Export Import Bank of India, Mumbai, Mr. B.N.Pranesh ceases to be the nominee Director of EXIM Bank on the Board of company, with immediate effect.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLP:IN 58.05 INR -0.90

BLP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BLP.
View Industry Companies

Industry Analysis


Industry Average

Valuation BLP Industry Range
Price/Earnings 12.7x
Price/Sales 0.4x
Price/Book 1.2x
Price/Cash Flow 7.7x
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAL PHARMA LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at